Trial Profile
Clinical Trials Insight: 700014346
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Jan 2007
Price :
$35
*
At a glance
- Drugs Cannabinor (Primary)
- Indications Pain
- Focus Adverse reactions; Therapeutic Use
- Sponsors Pharmos Corporation
- 23 Jan 2007 Status change
- 14 Aug 2006 New trial record.